BIOCRYST PHARMACEUTICALS INC (BCRX)       12.79  -0.17 (-1.31%)

12.79  -0.17 (-1.31%)

US09058V1035 - Common Stock - After market: 12.6 -0.19 (-1.49%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
238.44M157.17M17.81M48.84M20.65M
Non Recurring Items
N/A55.84M-2.01MN/A-15.90M
Cost Of Goods
4.52M7.26M1.68M4.10M470.00K
Gross Profit
233.92M149.91M16.14M44.73M20.18M
Operating Expenses
388.22M327.63M190.89M144.19M98.50M
Operating Income
-154.30M-177.72M-174.75M-99.46M-78.32M
Interest Expense
-89.98M-59.93M-6.05M-9.44M-7.03M
Income Before Taxes
-188.44M-181.81M-182.81M-108.90M-101.25M
Income Tax
4.91M2.25MN/AN/AN/A
Net Income
-193.35M-184.06M-182.81M-108.90M-101.25M
EBITDA
-153.09M-176.94M-174.00M-98.74M-77.55M
 
Per Share Data
EPS Diluted Total Ops
-1.04-1.03-1.09-0.94-0.98
Non GAAP EPS
-1.05-1.03-1.08-0.98-0.98
 
Statistics
Gross Profit Margin
98.11%95.38%90.62%91.58%97.72%
Profit Margin
-81.09%-117.11%-1026.45%-222.97%-490.31%
Operating Profit Margin
-64.71%-113.08%-981.19%-203.64%-379.27%

All data in USD

Charts